[HTML] mdpi.com

[HTML][HTML] Aducanumab—hope or disappointment for Alzheimer's disease

K Wojtunik-Kulesza, M Rudkowska… - International journal of …, 2023 - mdpi.com
In June 2021, the world was informed about a new drug for Alzheimer's disease approved
by the FDA. Aducanumab (BIIB037, ADU), being a monoclonal antibody IgG1, is the newest …
被引用次数：29 相关文章

Aducanumab—Hope or Disappointment for Alzheimer's Disease.

K Wojtunik-Kulesza, M Rudkowska… - International …, 2023 - search.ebscohost.com
In June 2021, the world was informed about a new drug for Alzheimer's disease approved
by the FDA. Aducanumab (BIIB037, ADU), being a monoclonal antibody IgG1, is the newest …

Aducanumab—Hope or Disappointment for Alzheimer's Disease

K Wojtunik-Kulesza, M Rudkowska… - … Journal of Molecular …, 2023 - europepmc.org
In June 2021, the world was informed about a new drug for Alzheimer's disease approved
by the FDA. Aducanumab (BIIB037, ADU), being a monoclonal antibody IgG1, is the newest …
[PDF] umlub.pl

[PDF][PDF] Aducanumab—Hope or Disappointment for Alzheimer's Disease

K Wojtunik-Kulesza, M Rudkowska… - 2023 - ppm.umlub.pl
In June 2021, the world was informed about a new drug for Alzheimer's disease approved
by the FDA. Aducanumab (BIIB037, ADU), being a monoclonal antibody IgG1, is the newest …

Aducanumab—Hope or Disappointment for Alzheimer's Disease

K Wojtunik-Kulesza, M Rudkowska… - International …, 2023 - search.proquest.com
In June 2021, the world was informed about a new drug for Alzheimer's disease approved
by the FDA. Aducanumab (BIIB037, ADU), being a monoclonal antibody IgG1, is the newest …
[HTML] nih.gov

[HTML][HTML] Aducanumab—Hope or Disappointment for Alzheimer's Disease

K Wojtunik-Kulesza, M Rudkowska… - … Journal of Molecular …, 2023 - ncbi.nlm.nih.gov
In June 2021, the world was informed about a new drug for Alzheimer's disease approved
by the FDA. Aducanumab (BIIB037, ADU), being a monoclonal antibody IgG1, is the newest …

Aducanumab-Hope or Disappointment for Alzheimer's Disease

K Wojtunik-Kulesza, M Rudkowska… - International …, 2023 - pubmed.ncbi.nlm.nih.gov
In June 2021, the world was informed about a new drug for Alzheimer's disease approved
by the FDA. Aducanumab (BIIB037, ADU), being a monoclonal antibody IgG1, is the newest …

Aducanumab-Hope or Disappointment for Alzheimer's Disease.

K Wojtunik-Kulesza, M Rudkowska… - … Journal of Molecular …, 2023 - europepmc.org
In June 2021, the world was informed about a new drug for Alzheimer's disease approved
by the FDA. Aducanumab (BIIB037, ADU), being a monoclonal antibody IgG1, is the newest …